MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-15-2026
Cyclacel Pharmaceuticals EV - Enterprise Value 2011-2026 | CYCC
Annual EV - Enterprise Value Cyclacel Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.16 M | 3.14 M | 12.5 M | -2.51 M | -2.22 M | 4.81 M | 3.15 M | -3.4 M | -6.55 M | 5.17 M | -2.79 M | -3.76 M | 31.4 M | 34 M | 10.7 M | -23 M | -11.5 M | -24.2 M | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 34 M | -24.2 M | 1.27 M |
EV - Enterprise Value of other stocks in the Biotechnology industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
4.15 M | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
1.82 B | - | 2.43 % | $ 254 M |  Germany |
 |
Happiness Biotech Group Limited
HAPP
|
6.3 M | - | 1.35 % | $ 17.8 M |  China |
 |
AgeX Therapeutics
AGE
|
3.93 M | - | -10.17 % | $ 12.2 K |  USA |
 |
I-Mab
IMAB
|
8.28 B | - | - | $ 866 M | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
525 M | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
168 B | - | 2.54 % | $ 160 B | France |
 |
AstraZeneca PLC
AZN
|
59.6 B | - | - | $ 96.9 B |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
-4.92 M | - | - | $ 269 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
686 M | - | 0.74 % | $ 768 M |  Israel |
 |
Galera Therapeutics
GRTX
|
-5.73 M | - | -32.59 % | $ 7.61 M | USA |
 |
Esperion Therapeutics
ESPR
|
1.16 B | $ 3.13 | - | $ 651 M | USA |
 |
Eton Pharmaceuticals
ETON
|
599 M | $ 34.45 | 4.74 % | $ 927 M | USA |
 |
Midatech Pharma plc
MTP
|
-1.76 M | - | -18.52 % | $ 27.3 M | Britain |
|
Forte Biosciences
FBRX
|
280 M | $ 20.31 | 1.2 % | $ 263 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - |  Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
11.4 M | - | - | $ 231 M | USA |
 |
Grifols, S.A.
GRFS
|
16.3 B | $ 8.19 | 4.46 % | $ 5.57 B |  Spain |
 |
Celyad Oncology SA
CYAD
|
-1.83 M | - | - | $ 12.5 M |  Belgium |
 |
Berkeley Lights
BLI
|
115 M | - | -7.31 % | $ 87 M | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
43.4 M | $ 6.82 | 1.94 % | $ 187 M | Israel |
 |
Generation Bio Co.
GBIO
|
68.7 M | - | - | $ 344 M | USA |
 |
IMV
IMV
|
23.6 M | - | - | $ 13.1 M | Canada |
 |
Akero Therapeutics
AKRO
|
2.99 B | - | - | $ 3.67 B | USA |
 |
BioNTech SE
BNTX
|
17.1 B | $ 90.36 | 2.93 % | $ 21.8 B | Germany |
 |
Autolus Therapeutics plc
AUTL
|
629 M | $ 1.62 | -0.61 % | $ 431 M | Britain |
 |
Ayala Pharmaceuticals
AYLA
|
5.32 M | - | - | $ 7.46 M | Israel |
 |
Cyclacel Pharmaceuticals
CYCCP
|
-2.16 M | - | -4.36 % | $ 27 M | USA |
 |
Compugen Ltd.
CGEN
|
106 M | $ 2.71 | -0.92 % | $ 253 M | Israel |
 |
Anika Therapeutics
ANIK
|
156 M | $ 15.14 | 2.16 % | $ 217 M | USA |
 |
Advaxis
ADXS
|
-3.02 M | - | -9.65 % | $ 45.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
10.3 M | - | 5.93 % | $ 314 M | Canada |
 |
Incyte Corporation
INCY
|
18.2 B | $ 97.08 | 1.55 % | $ 19 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-23.2 M | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
3.19 B | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
4.35 M | - | - | $ 26.5 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-721 K | $ 3.39 | 4.17 % | $ 5.58 M | Israel |
 |
AIkido Pharma
AIKI
|
9.53 M | - | 1.93 % | $ 17.4 M | USA |
 |
Aptose Biosciences
APTO
|
36.2 M | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
-18.3 M | - | -39.0 % | $ 4.57 M | USA |
 |
Coherus BioSciences
CHRS
|
335 M | $ 1.51 | 2.03 % | $ 177 M | USA |
 |
Akouos
AKUS
|
95.1 M | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
417 M | - | -0.23 % | $ 916 M | USA |
 |
AlloVir
ALVR
|
-55.1 M | - | 4.14 % | $ 49.1 M | USA |
 |
Allakos
ALLK
|
31 K | - | - | $ 28.6 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
3.64 B | $ 20.47 | 4.97 % | $ 2.6 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
-14.1 M | - | 3.16 % | $ 1.9 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-1.05 M | - | -11.43 % | $ 502 K | USA |